Executive leadership at TNFA.
Board of directors at TNFA.
Research analysts covering TNFA.
Recent press releases and 8-K filings for TNFA.
Q/C Technologies Announces Name and Ticker Change
TNFA
New Projects/Investments
Delisting/Listing Issues
- TNF Pharmaceuticals, Inc. officially changed its corporate name to Q/C Technologies, Inc., effective September 22, 2025, and its common stock began trading under the new Nasdaq ticker symbol "QCLS" on September 25, 2025.
- This transformation signifies a strategic pivot into quantum-class computing, leveraging exclusive global rights to LightSolver’s light-speed laser processing unit (LPU) for cryptocurrency verticals.
- The company is evaluating strategic options for its legacy therapeutic programs, isomyosamine and Supera-CBD.
- Current shareholders are not required to take any action, and the company's CUSIP number remains unchanged.
Sep 26, 2025, 9:10 PM
TNF Pharmaceuticals Secures Exclusive Rights for Cryptocurrency Computing
TNFA
New Projects/Investments
- TNF Pharmaceuticals, Inc. has entered a licensing agreement with LightSolver Ltd. for exclusive global rights to its innovative light speed computing accelerator for cryptocurrency and blockchain applications.
- LightSolver's technology, a laser-based processing unit (LPU), is designed to provide accelerated computation, aiming to reduce energy costs by up to 90% for crypto infrastructure.
- The company plans to change its name to reflect this new strategic direction into the computing sector.
Sep 2, 2025, 1:29 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more